knowledge -WSS

knowledge

author：knowledge 2025-09-01 04:26:35 - browse：36685

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： FTX founder Sam Bankman

hotspot

leisure time

WSS

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

FTX founder Sam Bankman

Lessons Learned: This is why you network to find that industry job you want

More regulation could be coming for drug ads

Germany receives 178 compensation applications from gay servicepeople over discrimination

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

focus

knowledge

The need-to-know this morning

Novavax’s money is going in the wrong direction

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Jerome Adams on the need for new antivirals for Covid

CDC launches VaccineFinder tool to locate Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Medicare details structure of new drug price negotiation program

‘The Bear’ and hospitality in hospitals

23andMe had bad news about my health. I wish a person had delivered it

Prior authorization reform is both possible and imperative

entertainment

Medicare drug price lawsuits could be good politics for Biden

To bolster infectious disease surveillance, genomics powerhouses team up

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

CVS is on a mission to consolidate health care. Will it work?

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

knowledge

hotspot

leisure time

entertainment